Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Treatment of adynamic bone disease in a haemodialysis patient with teriparatide.

Giamalis P, Economidou D, Dimitriadis C, Memmos D, Papagianni A, Efstratiadis G.

Clin Kidney J. 2015 Apr;8(2):188-90. doi: 10.1093/ckj/sfv005. Epub 2015 Feb 10.

2.

Impact of inflammation on anti-oxidative effects of vitamin E-coated membrane dialyzer in patients on chronic hemodialysis.

Kirmizis D, Papagianni A, Efstratiadis G, Memmos D.

Hemodial Int. 2014 Oct;18(4):751-7. doi: 10.1111/hdi.12154. Epub 2014 Mar 18.

PMID:
24641709
3.

Influence of body mass index on the association of weight changes with mortality in hemodialysis patients.

Cabezas-Rodriguez I, Carrero JJ, Zoccali C, Qureshi AR, Ketteler M, Floege J, London G, Locatelli F, Gorriz JL, Rutkowski B, Memmos D, Ferreira A, Covic A, Teplan V, Bos WJ, Kramar R, Pavlovic D, Goldsmith D, Nagy J, Benedik M, Verbeelen D, Tielemans C, Wüthrich RP, Martin PY, Martínez-Salgado C, Fernández-Martín JL, Cannata-Andia JB.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1725-33. doi: 10.2215/CJN.10951012. Epub 2013 Sep 5.

4.

Use of phosphate-binding agents is associated with a lower risk of mortality.

Cannata-Andía JB, Fernández-Martín JL, Locatelli F, London G, Gorriz JL, Floege J, Ketteler M, Ferreira A, Covic A, Rutkowski B, Memmos D, Bos WJ, Teplan V, Nagy J, Tielemans C, Verbeelen D, Goldsmith D, Kramar R, Martin PY, Wüthrich RP, Pavlovic D, Benedik M, Sánchez JE, Martínez-Camblor P, Naves-Díaz M, Carrero JJ, Zoccali C.

Kidney Int. 2013 Nov;84(5):998-1008. doi: 10.1038/ki.2013.185. Epub 2013 Jul 3.

PMID:
23823605
5.

Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients.

Pateinakis P, Papagianni A, Douma S, Efstratiadis G, Memmos D.

BMC Nephrol. 2013 Jun 12;14:122. doi: 10.1186/1471-2369-14-122.

6.

Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine.

Stangou M, Papagianni A, Bantis C, Moisiadis D, Kasimatis S, Spartalis M, Pantzaki A, Efstratiadis G, Memmos D.

Clin Nephrol. 2013 Sep;80(3):203-10. doi: 10.5414/CN107836.

PMID:
23611517
7.

Anti-inflammatory effects of simvastatin in diabetic compared to non-diabetic patients on chronic hemodialysis.

Kirmizis D, Papagianni A, Dogrammatzi F, Efstratiadis G, Memmos D.

J Diabetes. 2013 Dec;5(4):492-4. doi: 10.1111/1753-0407.12059. Epub 2013 Jun 4. No abstract available.

PMID:
23586806
8.

COSMOS: the dialysis scenario of CKD-MBD in Europe.

Fernández-Martín JL, Carrero JJ, Benedik M, Bos WJ, Covic A, Ferreira A, Floege J, Goldsmith D, Gorriz JL, Ketteler M, Kramar R, Locatelli F, London G, Martin PY, Memmos D, Nagy J, Naves-Díaz M, Pavlovic D, Rodríguez-García M, Rutkowski B, Teplan V, Tielemans C, Verbeelen D, Wüthrich RP, Martínez-Camblor P, Cabezas-Rodriguez I, Sánchez-Alvarez JE, Cannata-Andia JB.

Nephrol Dial Transplant. 2013 Jul;28(7):1922-35. doi: 10.1093/ndt/gfs418. Epub 2012 Nov 19.

9.

The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis.

Kirmizis D, Papagianni A, Dogrammatzi F, Belechri AM, Alexopoulos E, Efstratiadis G, Memmos D.

Ren Fail. 2012;34(9):1135-9. doi: 10.3109/0886022X.2012.717484. Epub 2012 Sep 6.

PMID:
22950641
10.

Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: a pilot study.

Mitsopoulos E, Ginikopoulou E, Economidou D, Zanos S, Pateinakis P, Minasidis E, Memmos D, Thodis E, Vargemezis V, Tsakiris D.

Am J Nephrol. 2012;36(3):238-44. Epub 2012 Aug 31.

PMID:
22948280
11.

Detection of multiple cytokines in the urine of patients with focal necrotising glomerulonephritis may predict short and long term outcome of renal function.

Stangou M, Papagianni A, Bantis C, Liakou H, Pliakos K, Giamalis P, Gionanlis L, Pantzaki A, Efstratiadis G, Memmos D.

Cytokine. 2012 Jan;57(1):120-6. doi: 10.1016/j.cyto.2011.10.003. Epub 2011 Nov 6.

PMID:
22057032
12.

Influence of aldosterone synthase gene C-344T polymorphism on focal segmental glomerulosclerosis.

Bantis C, Heering PJ, Stangou M, Kouri NM, Schwandt C, Memmos D, Rump LC, Ivens K.

Nephrology (Carlton). 2011 Nov;16(8):730-5. doi: 10.1111/j.1440-1797.2011.01497.x.

PMID:
21777344
13.

Steroids and azathioprine in the treatment of IgA nephropathy.

Stangou M, Ekonomidou D, Giamalis P, Liakou H, Tsiantoulas A, Pantzaki A, Papagianni A, Efstratiadis G, Alexopoulos E, Memmos D.

Clin Exp Nephrol. 2011 Jun;15(3):373-80. doi: 10.1007/s10157-011-0415-3. Epub 2011 Feb 8.

PMID:
21301920
14.

Acute kidney injury due to osmotic nephrosis following intraoperative placement of an intraperitoneal antiadhesive barrier.

Economidou D, Stavrinou E, Giamalis P, Dimitriadis C, Economou S, Memmos D.

Am J Kidney Dis. 2011 Feb;57(2):304-7. doi: 10.1053/j.ajkd.2010.10.044.

PMID:
21251542
15.

Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis.

Kirmizis D, Papagianni A, Belechri AM, Memmos D.

Nephrol Dial Transplant. 2011 Jul;26(7):2296-301. doi: 10.1093/ndt/gfq715. Epub 2010 Dec 2.

16.

Effects of simvastatin on markers of inflammation, oxidative stress and endothelial cell apoptosis in patients on chronic hemodialysis.

Kirmizis D, Papagianni A, Dogrammatzi F, Skoura L, Belechri AM, Alexopoulos E, Efstratiadis G, Memmos D.

J Atheroscler Thromb. 2010 Dec 26;17(12):1256-65. Epub 2010 Sep 25.

17.

New insights of osmoregulatory system changes in ovarian hyperstimulation syndrome.

Bili H, Tsolakidis D, Stangou M, Zafrakas M, Pados G, Memmos D, Tarlatzis BC.

Fertil Steril. 2011 Jan;95(1):304-6. doi: 10.1016/j.fertnstert.2010.08.008. Epub 2010 Sep 20.

PMID:
20850728
18.

Osmotic nephrosis due to the use of anti-adhesive membrane intraperitoneally.

Economidou D, Kapoukranidou D, Dimitriadis C, Xioufi D, Pantzaki A, Anagnostou E, Memmos D.

Nephrol Dial Transplant. 2011 Feb;26(2):697-701. doi: 10.1093/ndt/gfq399. Epub 2010 Jul 5.

19.

FGF-23 Levels before and after Renal Transplantation.

Economidou D, Dovas S, Papagianni A, Pateinakis P, Memmos D.

J Transplant. 2009;2009:379082. doi: 10.1155/2009/379082. Epub 2009 May 17.

20.

Is presence of ANCA in crescentic IgA nephropathy a coincidence or novel clinical entity? A case series.

Bantis C, Stangou M, Schlaugat C, Alexopoulos E, Pantzaki A, Memmos D, Ivens K, Heering PJ.

Am J Kidney Dis. 2010 Feb;55(2):259-68. doi: 10.1053/j.ajkd.2009.09.031. Epub 2009 Dec 30.

PMID:
20042261
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk